HK Stock MarketDetailed Quotes

01681 CONSUN PHARMA

Watchlist
  • 7.800
  • -0.130-1.64%
Market Closed Dec 13 16:08 CST
6.62BMarket Cap7.23P/E (TTM)

CONSUN PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
----
15.72%863.7M
----
7.26%746.39M
----
19.21%695.86M
----
336.72%583.74M
----
-78.33%133.66M
Profit adjustment
Interest (income) - adjustment
----
-31.49%-68.92M
----
-33.55%-52.41M
----
-40.73%-39.25M
----
-66.49%-27.89M
----
-48.03%-16.75M
Impairment and provisions:
----
97.49%-267K
----
-281.75%-10.63M
----
-85.79%5.85M
----
-89.71%41.18M
----
3,070.91%400.14M
-Impairmen of inventory (reversal)
----
-43.60%12.33M
----
-8.52%21.86M
----
102.25%23.89M
----
223.32%11.81M
----
34.09%3.65M
-Impairment of trade receivables (reversal)
----
61.23%-12.6M
----
-80.09%-32.49M
----
---18.04M
----
----
----
----
-Impairment of goodwill
----
----
----
----
----
----
----
----
----
--320.65M
-Other impairments and provisions
----
----
----
----
----
----
----
-61.28%29.36M
----
666.48%75.84M
Asset sale loss (gain):
----
-79.48%846K
----
107.14%4.12M
----
715.57%1.99M
----
-26.06%244K
----
42.86%330K
-Loss (gain) on sale of property, machinery and equipment
----
-79.48%846K
----
107.14%4.12M
----
715.57%1.99M
----
-26.06%244K
----
42.86%330K
Depreciation and amortization:
----
2.27%78.09M
----
4.61%76.36M
----
1.66%72.99M
----
-1.81%71.8M
----
2.23%73.12M
-Depreciation
----
2.27%78.09M
----
4.61%76.36M
----
1.66%72.99M
----
-1.81%71.8M
----
2.23%73.12M
Financial expense
----
94.49%21.26M
----
-15.28%10.93M
----
-39.70%12.91M
----
-26.31%21.4M
----
5.73%29.04M
Exchange Loss (gain)
----
-2.72%9.03M
----
181.92%9.28M
----
58.61%-11.33M
----
-214.22%-27.37M
----
7.72%23.96M
Special items
----
----
----
-107.62%-1.78M
----
92.45%23.41M
----
-38.93%12.17M
----
79.62%19.92M
Operating profit before the change of operating capital
----
15.53%903.74M
----
2.60%782.25M
----
12.91%762.43M
----
1.79%675.26M
----
-11.61%663.42M
Change of operating capital
Inventory (increase) decrease
----
-85.82%-102.02M
----
-38.80%-54.9M
----
-38.77%-39.56M
----
-607.65%-28.5M
----
69.10%-4.03M
Accounts receivable (increase)decrease
----
-101.50%-1.71M
----
-0.29%113.87M
----
-62.49%114.21M
----
1,089.33%304.46M
----
-62.27%25.6M
Accounts payable increase (decrease)
----
-29.41%80.76M
----
124.38%114.41M
----
23.06%50.99M
----
129.66%41.43M
----
-294.52%-139.67M
prepayments (increase)decrease
----
-307.93%-6.24M
----
-83.36%3M
----
297.44%18.04M
----
---9.14M
----
----
Special items for working capital changes
----
-130.54%-690K
----
35.03%2.26M
----
247.27%1.67M
----
31.57%-1.14M
----
28.45%-1.66M
Cash  from business operations
36.92%376.26M
-9.06%873.85M
-18.35%274.81M
5.85%960.89M
0.15%336.56M
-7.59%907.79M
-18.20%336.05M
80.70%982.38M
67.04%410.79M
-37.86%543.65M
China income tax paid
-24.41%-25.92M
-315.45%-54.87M
-447.20%-20.83M
92.75%-13.21M
97.33%-3.81M
-58.04%-182.25M
-63.53%-142.33M
28.08%-115.32M
17.95%-87.04M
-32.91%-160.34M
Net cash from operations
37.94%350.34M
-13.58%818.97M
-23.67%253.98M
30.62%947.68M
71.77%332.75M
-16.32%725.54M
-40.16%193.72M
126.20%867.06M
131.51%323.76M
-49.18%383.32M
Cash flow from investment activities
Interest received - investment
56.87%47.19M
53.35%68.92M
52.40%30.08M
40.69%44.94M
13.86%19.74M
14.54%31.94M
0.41%17.34M
66.49%27.89M
208.32%17.27M
48.69%16.75M
Restricted cash (increase) decrease
----
----
----
200.00%2.32M
200.00%2.32M
---2.32M
---2.32M
----
----
----
Decrease in deposits (increase)
-311.29%-150.38M
31.57%-245.77M
125.42%71.17M
-56.16%-359.17M
6.67%-280M
---230M
---300M
----
----
----
Sale of fixed assets
245.65%477K
-87.89%145K
-74.11%138K
271.74%1.2M
85.07%533K
187.50%322K
39.81%288K
-89.26%112K
-69.66%206K
-18.39%1.04M
Purchase of fixed assets
-179.71%-46.92M
-1.89%-52.56M
39.14%-16.78M
47.49%-51.59M
25.28%-27.56M
-101.73%-98.25M
-16.95%-36.89M
72.90%-48.7M
72.43%-31.54M
7.03%-179.75M
Purchase of intangible assets
----
----
----
----
----
----
----
-2,677.78%-5M
---5M
---180K
Cash on investment
-11.11%-10M
61.54%-2.5M
-30.62%-9M
---6.5M
---6.89M
----
----
----
----
----
Other items in the investment business
----
----
----
----
----
----
----
----
----
--52M
Net cash from investment operations
-311.10%-159.63M
37.16%-231.77M
125.91%75.62M
-23.63%-368.8M
9.24%-291.86M
-1,060.58%-298.31M
-1,586.33%-321.58M
76.66%-25.7M
82.36%-19.07M
39.09%-110.13M
Net cash before financing
-42.14%190.71M
1.44%587.2M
706.10%329.59M
35.49%578.88M
131.98%40.89M
-49.22%427.23M
-141.96%-127.86M
207.98%841.36M
860.10%304.69M
-52.36%273.18M
Cash flow from financing activities
New borrowing
-24.45%220.2M
70.59%442.39M
39.25%291.48M
-12.31%259.32M
-2.98%209.32M
12.12%295.72M
0.93%215.75M
-56.58%263.76M
-52.85%213.76M
--607.46M
Refund
0.47%-218.21M
12.54%-379.42M
38.03%-219.25M
-86.28%-433.81M
-92.64%-353.81M
2.12%-232.88M
2.32%-183.66M
48.27%-237.92M
-40.87%-188.02M
-133.48%-459.97M
Issuing shares
1,257.16%124.07M
438.36%14.2M
246.55%9.14M
-81.89%2.64M
-70.19%2.64M
--14.57M
--8.85M
----
----
-55.71%2.49M
Interest paid - financing
-708.70%-186K
-94.32%-1.09M
---23K
-64.14%-563K
----
---343K
----
----
-20.85%-11.49M
----
Dividends paid - financing
-114.36%-453.88M
-158.78%-329.93M
-66.08%-211.74M
35.64%-127.49M
4.82%-127.49M
-50.64%-198.08M
-81.37%-133.95M
44.21%-131.49M
49.41%-73.86M
-200.21%-235.71M
Issuance expenses and redemption of securities expenses
----
----
----
3.60%-29.07M
---29.07M
80.26%-30.15M
----
-230.53%-152.75M
-138.99%-106.59M
---46.21M
Other items of the financing business
-89.17%-13.19M
-119.26%-22.74M
-82.66%-6.97M
17.45%-10.37M
27.17%-3.82M
41.30%-12.56M
---5.24M
13.43%-21.4M
----
-9.74%-24.72M
Net cash from financing operations
-148.49%-341.79M
18.15%-280.1M
54.49%-137.55M
-105.33%-342.21M
-207.60%-302.23M
40.44%-166.66M
40.88%-98.26M
-78.60%-279.8M
-238.10%-166.21M
46.43%-156.66M
Effect of rate
-164.22%-1.27M
-152.46%-9.01M
-65.02%1.98M
479.84%17.18M
326.02%5.65M
-0.29%-4.52M
340.22%1.33M
-48.60%-4.51M
-401.82%-552K
-279.38%-3.04M
Net Cash
-178.67%-151.08M
29.76%307.1M
173.48%192.05M
-9.17%236.67M
-15.58%-261.35M
-53.60%260.57M
-263.28%-226.12M
381.93%561.55M
-8.94%138.48M
-58.53%116.52M
Begining period cash
12.17%2.75B
11.56%2.45B
11.56%2.45B
13.20%2.2B
13.20%2.2B
40.27%1.94B
40.27%1.94B
8.94%1.38B
8.94%1.38B
28.31%1.27B
Cash at the end
-1.83%2.6B
12.17%2.75B
36.25%2.64B
11.56%2.45B
13.12%1.94B
13.20%2.2B
12.77%1.72B
40.27%1.94B
6.99%1.52B
8.94%1.38B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax ----15.72%863.7M----7.26%746.39M----19.21%695.86M----336.72%583.74M-----78.33%133.66M
Profit adjustment
Interest (income) - adjustment -----31.49%-68.92M-----33.55%-52.41M-----40.73%-39.25M-----66.49%-27.89M-----48.03%-16.75M
Impairment and provisions: ----97.49%-267K-----281.75%-10.63M-----85.79%5.85M-----89.71%41.18M----3,070.91%400.14M
-Impairmen of inventory (reversal) -----43.60%12.33M-----8.52%21.86M----102.25%23.89M----223.32%11.81M----34.09%3.65M
-Impairment of trade receivables (reversal) ----61.23%-12.6M-----80.09%-32.49M-------18.04M----------------
-Impairment of goodwill --------------------------------------320.65M
-Other impairments and provisions -----------------------------61.28%29.36M----666.48%75.84M
Asset sale loss (gain): -----79.48%846K----107.14%4.12M----715.57%1.99M-----26.06%244K----42.86%330K
-Loss (gain) on sale of property, machinery and equipment -----79.48%846K----107.14%4.12M----715.57%1.99M-----26.06%244K----42.86%330K
Depreciation and amortization: ----2.27%78.09M----4.61%76.36M----1.66%72.99M-----1.81%71.8M----2.23%73.12M
-Depreciation ----2.27%78.09M----4.61%76.36M----1.66%72.99M-----1.81%71.8M----2.23%73.12M
Financial expense ----94.49%21.26M-----15.28%10.93M-----39.70%12.91M-----26.31%21.4M----5.73%29.04M
Exchange Loss (gain) -----2.72%9.03M----181.92%9.28M----58.61%-11.33M-----214.22%-27.37M----7.72%23.96M
Special items -------------107.62%-1.78M----92.45%23.41M-----38.93%12.17M----79.62%19.92M
Operating profit before the change of operating capital ----15.53%903.74M----2.60%782.25M----12.91%762.43M----1.79%675.26M-----11.61%663.42M
Change of operating capital
Inventory (increase) decrease -----85.82%-102.02M-----38.80%-54.9M-----38.77%-39.56M-----607.65%-28.5M----69.10%-4.03M
Accounts receivable (increase)decrease -----101.50%-1.71M-----0.29%113.87M-----62.49%114.21M----1,089.33%304.46M-----62.27%25.6M
Accounts payable increase (decrease) -----29.41%80.76M----124.38%114.41M----23.06%50.99M----129.66%41.43M-----294.52%-139.67M
prepayments (increase)decrease -----307.93%-6.24M-----83.36%3M----297.44%18.04M-------9.14M--------
Special items for working capital changes -----130.54%-690K----35.03%2.26M----247.27%1.67M----31.57%-1.14M----28.45%-1.66M
Cash  from business operations 36.92%376.26M-9.06%873.85M-18.35%274.81M5.85%960.89M0.15%336.56M-7.59%907.79M-18.20%336.05M80.70%982.38M67.04%410.79M-37.86%543.65M
China income tax paid -24.41%-25.92M-315.45%-54.87M-447.20%-20.83M92.75%-13.21M97.33%-3.81M-58.04%-182.25M-63.53%-142.33M28.08%-115.32M17.95%-87.04M-32.91%-160.34M
Net cash from operations 37.94%350.34M-13.58%818.97M-23.67%253.98M30.62%947.68M71.77%332.75M-16.32%725.54M-40.16%193.72M126.20%867.06M131.51%323.76M-49.18%383.32M
Cash flow from investment activities
Interest received - investment 56.87%47.19M53.35%68.92M52.40%30.08M40.69%44.94M13.86%19.74M14.54%31.94M0.41%17.34M66.49%27.89M208.32%17.27M48.69%16.75M
Restricted cash (increase) decrease ------------200.00%2.32M200.00%2.32M---2.32M---2.32M------------
Decrease in deposits (increase) -311.29%-150.38M31.57%-245.77M125.42%71.17M-56.16%-359.17M6.67%-280M---230M---300M------------
Sale of fixed assets 245.65%477K-87.89%145K-74.11%138K271.74%1.2M85.07%533K187.50%322K39.81%288K-89.26%112K-69.66%206K-18.39%1.04M
Purchase of fixed assets -179.71%-46.92M-1.89%-52.56M39.14%-16.78M47.49%-51.59M25.28%-27.56M-101.73%-98.25M-16.95%-36.89M72.90%-48.7M72.43%-31.54M7.03%-179.75M
Purchase of intangible assets -----------------------------2,677.78%-5M---5M---180K
Cash on investment -11.11%-10M61.54%-2.5M-30.62%-9M---6.5M---6.89M--------------------
Other items in the investment business --------------------------------------52M
Net cash from investment operations -311.10%-159.63M37.16%-231.77M125.91%75.62M-23.63%-368.8M9.24%-291.86M-1,060.58%-298.31M-1,586.33%-321.58M76.66%-25.7M82.36%-19.07M39.09%-110.13M
Net cash before financing -42.14%190.71M1.44%587.2M706.10%329.59M35.49%578.88M131.98%40.89M-49.22%427.23M-141.96%-127.86M207.98%841.36M860.10%304.69M-52.36%273.18M
Cash flow from financing activities
New borrowing -24.45%220.2M70.59%442.39M39.25%291.48M-12.31%259.32M-2.98%209.32M12.12%295.72M0.93%215.75M-56.58%263.76M-52.85%213.76M--607.46M
Refund 0.47%-218.21M12.54%-379.42M38.03%-219.25M-86.28%-433.81M-92.64%-353.81M2.12%-232.88M2.32%-183.66M48.27%-237.92M-40.87%-188.02M-133.48%-459.97M
Issuing shares 1,257.16%124.07M438.36%14.2M246.55%9.14M-81.89%2.64M-70.19%2.64M--14.57M--8.85M---------55.71%2.49M
Interest paid - financing -708.70%-186K-94.32%-1.09M---23K-64.14%-563K-------343K---------20.85%-11.49M----
Dividends paid - financing -114.36%-453.88M-158.78%-329.93M-66.08%-211.74M35.64%-127.49M4.82%-127.49M-50.64%-198.08M-81.37%-133.95M44.21%-131.49M49.41%-73.86M-200.21%-235.71M
Issuance expenses and redemption of securities expenses ------------3.60%-29.07M---29.07M80.26%-30.15M-----230.53%-152.75M-138.99%-106.59M---46.21M
Other items of the financing business -89.17%-13.19M-119.26%-22.74M-82.66%-6.97M17.45%-10.37M27.17%-3.82M41.30%-12.56M---5.24M13.43%-21.4M-----9.74%-24.72M
Net cash from financing operations -148.49%-341.79M18.15%-280.1M54.49%-137.55M-105.33%-342.21M-207.60%-302.23M40.44%-166.66M40.88%-98.26M-78.60%-279.8M-238.10%-166.21M46.43%-156.66M
Effect of rate -164.22%-1.27M-152.46%-9.01M-65.02%1.98M479.84%17.18M326.02%5.65M-0.29%-4.52M340.22%1.33M-48.60%-4.51M-401.82%-552K-279.38%-3.04M
Net Cash -178.67%-151.08M29.76%307.1M173.48%192.05M-9.17%236.67M-15.58%-261.35M-53.60%260.57M-263.28%-226.12M381.93%561.55M-8.94%138.48M-58.53%116.52M
Begining period cash 12.17%2.75B11.56%2.45B11.56%2.45B13.20%2.2B13.20%2.2B40.27%1.94B40.27%1.94B8.94%1.38B8.94%1.38B28.31%1.27B
Cash at the end -1.83%2.6B12.17%2.75B36.25%2.64B11.56%2.45B13.12%1.94B13.20%2.2B12.77%1.72B40.27%1.94B6.99%1.52B8.94%1.38B
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --KPMG--KPMG--KPMG--KPMG--KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Traditional Chinese Medicine
Traditional Chinese Medicine
Intraday-1.45%